Speaker
Prof.
Peter Rogers
(University of melbourne)
Description
Microbeam radiotherapy (MRT) was proposed as a novel RT paradigm for treating cancer some time ago. However, progress has been slow and it is unclear when or if human cancers will be treated with synchrotron radiation. There are numerous biological, medical, technical, regulatory and ethical issues to consider before a human is subjected to synchrotron MRT.
This talk will give an overview of the issues that are being, and still need to be, addressed. Latest data from the current AS/IMBL MRT program will also be presented.
| Are you a student? | No |
|---|---|
| Do you wish to take part in</br>the Student Poster Slam? | No |
| Are you an ECR? (<5 yrs</br>since PhD/Masters) | No |
| Keywords or phrases (comma separated) | microbeam radiotherapy, cancer, human |
| What is your gender? | Male |
Primary author
Prof.
Peter Rogers
(University of melbourne)
